… is promising, although under investigation. Application of CAR-T regs in autoimmune diseases - Matteo Doglio Matteo Doglio gave updates on ongoing studies for CAR-T regs in SLE, a very promising and rapidly evolving …

… after patients receiving Immune effector cells such as CAR-T therapy, anywhere in the patient pathway. The forum can be …

… and set limits. With the new treatment of CAR-T and other therapies, and the ever-growing requests for … because this delay means that the proper forms for CAR-T / IEC were not developed in PROMISE, and now we are …

… and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma … infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy Kitsada Wudhikarn & Miguel-Angel Perales Get …

… the pick of our recent most highly cited articles? Non-T depleted haploidentical stem cell transplantation in AML … Toshiyuki Ueno et al. Efficacy and safety of CAR-T cell therapy in minorities Astha Thakkar et al. Chimerism …

… transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: … a real-world experience Marta Castelli et al   Anti-T-lymphocyte globulin improves GvHD-free and relapse-free …

… sclerosis. Recently, innovative cellular therapies (i.e. CAR-T cells, mesenchymal cells, Tregs-based therapies) have been …

… sclerosis (SSc). Recently, novel cellular therapies (i.e. CAR-T cells, mesenchymal cells) have been successfully adopted in …

… 2025   The Use of Cell Therapies for Autoimmune Diseases: CAR-T From Biology to Clinical Application  Paris, France 16-17 …

… Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, …